Program (preliminary)
SATURDAY JULY 26, 2008 · 8:30am–5:30pm · PLAZA BALLROOM · HYATT REGENCY · CHICAGO, USA
MORNING SESSION
| 09:00 a.m. - 09:15 a.m. | Introduction – Jeffrey Noebels, MD, PhD (Baylor College of Medicine) |
| 09:15 a.m. - 09:45 a.m. | Evidence for Epilepsy in AD Models and Relation to Cognitive Impairments – Lennart Mucke, MD (Gladstone Institutes and UCSF) |
| 09:45 a.m. - 10:15 a.m. | Effects of Aβ on Synaptic Functions – Roberto Malinow, PhD (Cold Spring Harbor Laboratory) |
| 10:15 a.m. - 10:45 a.m. | Role of Endogenous Synaptic Activity and Endocytosis in Aβ Release in Vivo – David Holtzman, MD (Washington University School of Medicine) |
| 10:45 a.m. - 11:15 a.m. | Break |
| 11:15 a.m. - 11:45 a.m. | Role of BACE1 in the Regulation of Sodium Channel Activity – Dora Kovacs, PhD (Massachusetts General Institute for Neurodegenerative Disease and Harvard Medical School) |
| 11:45 a.m. - 12:15 a.m. | Role of Sodium Channels in Epilepsy – Lori Isom, PhD (University of Michigan School of Medicine) |
| 12:30 p.m. - 01:30 p.m. | Lunch on your own |
AFTERNOON SESSION
| 01:30 p.m. - 02:00 p.m. | Clinical Evidence for Epilepsy in AD – Allen Hauser, MD (Columbia University) |
| 02:00 p.m. - 02:30 p.m. | Detecting Nonconvulsive Seizure Activity in Humans – Andrew Cole, MD (Massachusetts General Hospital and Harvard Medical School) |
| 02:30 p.m. - 03:00 p.m. | Role of Neural System Remodeling in AD – Bradley Hyman, MD, PhD (Massachusetts General Hospital and Harvard Medical School) |
| 03:00 p.m. - 03:30 p.m. | Break |
| 03:30 p.m. - 04:00 p.m. | Polygenic Aspects of AD and Epilepsy: Is there an Overlap? – Jeffrey Noebels, MD, PhD (Baylor College of Medicine) |
| 04:00 p.m. - 04:30 p.m. | Pharmacological Aspects of AD and Epilepsy: Is there an Overlap? – Marc Dichter, MD, PhD (University of Pennsylvania) |
| 04:30 p.m. - 05:30 p.m. | Roundtable Discussion: Role of Epilepsy in AD Pathogenesis and Therapeutic Implications |
